Radiopharm Theranostics Ltd
ASX:RAD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
R
|
Radiopharm Theranostics Ltd
ASX:RAD
|
AU |
|
Hycroft Mining Holding Corporation
NASDAQ:HYMC
|
US |
Income Statement
Earnings Waterfall
Radiopharm Theranostics Ltd
Income Statement
Radiopharm Theranostics Ltd
| Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|
| Revenue | |||||||
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
2
+462%
|
4
+116%
|
4
+0%
|
|
| Gross Profit | |||||||
| Cost of Revenue |
0
|
0
|
0
|
(2)
|
(4)
|
(3)
|
|
| Gross Profit |
0
N/A
|
0
N/A
|
0
N/A
|
(0)
N/A
|
0
N/A
|
0
+850%
|
|
| Operating Income | |||||||
| Operating Expenses |
(35)
|
(41)
|
(37)
|
(38)
|
(34)
|
(41)
|
|
| Selling, General & Administrative |
(15)
|
(16)
|
(16)
|
(15)
|
(17)
|
(19)
|
|
| Research & Development |
(22)
|
(31)
|
(20)
|
(22)
|
(25)
|
(35)
|
|
| Depreciation & Amortization |
(3)
|
0
|
(3)
|
0
|
(3)
|
0
|
|
| Other Operating Expenses |
6
|
6
|
1
|
(2)
|
10
|
13
|
|
| Operating Income |
(34)
N/A
|
(41)
-20%
|
(37)
+10%
|
(38)
-2%
|
(34)
+11%
|
(41)
-21%
|
|
| Pre-Tax Income | |||||||
| Interest Income Expense |
(0)
|
(6)
|
(11)
|
(4)
|
(4)
|
(6)
|
|
| Pre-Tax Income |
(35)
N/A
|
(47)
-35%
|
(48)
-2%
|
(43)
+11%
|
(38)
+10%
|
(47)
-22%
|
|
| Net Income | |||||||
| Tax Provision |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Income from Continuing Operations |
(35)
|
(47)
|
(48)
|
(43)
|
(38)
|
(47)
|
|
| Income to Minority Interest |
0
|
0
|
0
|
1
|
2
|
2
|
|
| Net Income (Common) |
(35)
N/A
|
(47)
-35%
|
(48)
-2%
|
(42)
+13%
|
(37)
+12%
|
(45)
-22%
|
|
| EPS (Diluted) |
-0.11
N/A
|
-0.13
-18%
|
-0.12
+8%
|
-0.02
+83%
|
-0.02
N/A
|
-0.02
N/A
|
|